As of September 2024, Helix Biopharma has a market cap of $185.17M. This makes Helix Biopharma the world's 17079th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $24.21M | -19.05% |
2023 | $29.91M | -4.55% |
2022 | $31.34M | -26.67% |
2021 | $42.73M | -40.00% |
2020 | $71.22M | -62.69% |
2019 | $190.86M | 152.83% |
2018 | $75.49M | -43.62% |
2017 | $133.89M | -38.96% |
2016 | $219.35M | -23.00% |
2015 | $284.87M | 11.11% |
2014 | $256.38M | 25.00% |
2013 | $205.11M | 22.03% |
2012 | $168.07M | -37.89% |
2011 | $270.63M | -26.07% |
2010 | $366.06M | -19.94% |
2009 | $457.22M | 68.95% |
2008 | $270.63M | -13.64% |
2007 | $313.36M | 18.92% |
2006 | $263.51M | -55.10% |
2005 | $586.84M | 17.71% |
2004 | $498.53M | -20.45% |
2003 | $626.72M | 47.16% |
2002 | $425.88M | 22.54% |
2001 | $347.54M | -61.88% |
2000 | $911.59M | 218.41% |
1999 | $286.30M | 402.50% |
1998 | $56.97M | 0.00% |
1997 | $56.97M | -75.76% |
1996 | $235.02M | - |